Transient vasopressin-resistant diabetes insipidus of pregnancy. 1984

W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D003919 Diabetes Insipidus A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin

Related Publications

W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
August 1986, Obstetrics and gynecology,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
November 1986, Obstetrics and gynecology,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
May 1963, Nordisk medicin,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
March 1959, A.M.A. journal of diseases of children,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
March 1962, Ugeskrift for laeger,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
August 1987, European journal of obstetrics, gynecology, and reproductive biology,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
November 1989, Obstetrical & gynecological survey,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
June 2003, Internal medicine (Tokyo, Japan),
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
January 2015, Endocrinology, diabetes & metabolism case reports,
W M Barron, and L H Cohen, and L A Ulland, and W E Lassiter, and E M Fulghum, and D Emmanouel, and G Robertson, and M D Lindheimer
February 1960, A.M.A. journal of diseases of children,
Copied contents to your clipboard!